In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Penumbra (PEN) to $250 from $235 and keeps an Overweight rating on the ...

The following is a summary of “Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter ...

Key Takeaways ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein thrombosis, especially during the weeks immediately after surgery. Current ...

LOUISVILLE, Ky. -- Large tumor size and high disease grade were associated with an increased risk of early cancer-related ...

A new blood vessel-like coating could make medical devices including catheters and stents safer for millions of patients, ...

The study added to a limited database about the effects of perioperative IO combinations, which have emerged as standard of ...